Literature DB >> 11864804

Benzodiazepine use and risk of dementia: a nested case-control study.

Rajaa Lagnaoui1, Bernard Bégaud, Nicholas Moore, Anicet Chaslerie, Annie Fourrier, Luc Letenneur, Jean François Dartigues, Yola Moride.   

Abstract

The objective of this article was to examine the possible association between benzodiazepine use and the risk of dementia in the elderly. This was a nested case--control study set in community settings in Bordeaux area, France. The participants were a representative sample of 3,777 elderly persons (65 years of age and older) followed from 1989 to 1997. The main outcome measures were the use of benzodiazepines in incident cases of dementia versus nondemented controls. On the basis of medical and psychological data, 150 patients were diagnosed with dementia according to the criteria of the third revision of the Diagnostic and Statistical Manual of Mental Disorders. Information on benzodiazepine use was obtained by face-to-face interview and visual assessment of patient's medicine chest by a trained neuropsychologist. After controlling for age, gender, education level, living alone, wine consumption, psychiatric history, and depressive symptomatology, ever use of benzodiazepines was associated with a significantly increased risk of dementia [adjusted odds ratio (OR), 1.7; 95% confidence interval, 1.2-2.4]. Former use was associated with a significantly increased risk of dementia (adjusted OR, 2.3; 95% CI,1.2-4.5). No association was found between dementia and the current use of benzodiazepines (adjusted OR, 1.0; 95% CI, 0.6-1.6). Our finding suggest that former use of benzodiazepines could be a risk factor for dementia, but more detailed investigation are needed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11864804     DOI: 10.1016/s0895-4356(01)00453-x

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  35 in total

1.  Impact of long-term benzodiazepine use on cognitive functioning in young adults: the VISAT cohort.

Authors:  Olivia Boeuf-Cazou; Bienvenu Bongue; David Ansiau; Jean-Claude Marquié; Maryse Lapeyre-Mestre
Journal:  Eur J Clin Pharmacol       Date:  2011-04-15       Impact factor: 2.953

2.  Anxiety symptoms and risk of dementia and mild cognitive impairment in the oldest old women.

Authors:  Ahmed M Kassem; Mary Ganguli; Kristine Yaffe; Joseph T Hanlon; Oscar L Lopez; John W Wilson; Kristine Ensrud; Jane A Cauley
Journal:  Aging Ment Health       Date:  2017-01-10       Impact factor: 3.658

3.  Benzodiazepine Use and Risk of Developing Alzheimer's Disease: A Case-Control Study Based on Swiss Claims Data.

Authors:  Fabienne A Biétry; Alena M Pfeil; Oliver Reich; Matthias Schwenkglenks; Christoph R Meier
Journal:  CNS Drugs       Date:  2017-03       Impact factor: 5.749

4.  Hypnotics and the Risks of Dementia.

Authors:  Walter James
Journal:  J Clin Sleep Med       Date:  2017-06-15       Impact factor: 4.062

5.  Psychotropic drug use and cognitive rehabilitation practice for elderly patients.

Authors:  Eiji Kose; Toshiyuki Hirai; Toshiichi Seki
Journal:  Int J Clin Pharm       Date:  2018-08-21

6.  Benzodiazepine Use and Cognitive Decline in Elderly With Normal Cognition.

Authors:  Yuhai Zhang; Xiao-Hua Zhou; Dana H Meranus; Linbo Wang; Walter A Kukull
Journal:  Alzheimer Dis Assoc Disord       Date:  2016 Apr-Jun       Impact factor: 2.703

7.  The effects of commonly prescribed drugs in patients with Alzheimer's disease on the rate of deterioration.

Authors:  J Ellul; N Archer; C M L Foy; M Poppe; H Boothby; H Nicholas; R G Brown; S Lovestone
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-09-29       Impact factor: 10.154

Review 8.  The Benzodiazepine-Dementia Disorders Link: Current State of Knowledge.

Authors:  Antoine Pariente; Sophie Billioti de Gage; Nicholas Moore; Bernard Bégaud
Journal:  CNS Drugs       Date:  2016-01       Impact factor: 5.749

9.  A Systematic Review and Meta-Analysis of the Risk of Dementia Associated with Benzodiazepine Use, After Controlling for Protopathic Bias.

Authors:  Ross Penninkilampi; Guy D Eslick
Journal:  CNS Drugs       Date:  2018-06       Impact factor: 5.749

10.  Patterns and correlates of benzodiazepine use in the French general population.

Authors:  Rajaa Lagnaoui; Fanny Depont; Annie Fourrier; Abdelillah Abouelfath; Bernard Bégaud; Hélène Verdoux; Nicholas Moore
Journal:  Eur J Clin Pharmacol       Date:  2004-09       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.